RAD51 and neoplasm: In the recent studies, 135G/C polymorphism of RAD51 may be associated with an elevated tumour risk in the Polish populations, regarding TNBC [28], while there are still no data, which would be illustrating the significance of RAD51 polymorphism for triple-negative breast cancer development in other populations.